MAP2K5 and melanoma: Consistent with Tusa et al. (2018), BRAFV600E-mutant melanoma cells were sensitive to ERK5 pathway inhibition using the MEK5 inhibitor, BIX02189 (Benito-Jardón et al., 2019).